 Norman Friedman
Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 47 | 2025 | 238 | 16.700 |
Why?
| | Tonsillectomy | 35 | 2024 | 78 | 16.280 |
Why?
| | Adenoidectomy | 26 | 2024 | 67 | 7.740 |
Why?
| | Sleep Apnea Syndromes | 11 | 2024 | 78 | 4.700 |
Why?
| | Polysomnography | 25 | 2025 | 155 | 4.670 |
Why?
| | Down Syndrome | 12 | 2024 | 454 | 4.150 |
Why?
| | Endoscopy | 7 | 2024 | 268 | 1.520 |
Why?
| | Pediatric Obesity | 5 | 2025 | 568 | 1.510 |
Why?
| | Child | 57 | 2024 | 20860 | 1.500 |
Why?
| | Otitis Media | 8 | 2023 | 163 | 1.160 |
Why?
| | Practice Patterns, Physicians' | 6 | 2023 | 1284 | 1.120 |
Why?
| | Child, Preschool | 36 | 2024 | 10462 | 1.120 |
Why?
| | Sleep | 7 | 2023 | 657 | 1.110 |
Why?
| | Retrospective Studies | 22 | 2024 | 14562 | 0.910 |
Why?
| | Otolaryngology | 4 | 2020 | 84 | 0.880 |
Why?
| | Parents | 5 | 2024 | 1304 | 0.870 |
Why?
| | Humans | 79 | 2025 | 129078 | 0.810 |
Why?
| | Palatine Tonsil | 3 | 2024 | 45 | 0.780 |
Why?
| | Perception | 2 | 2024 | 336 | 0.780 |
Why?
| | Larynx | 1 | 2022 | 54 | 0.760 |
Why?
| | Pediatrics | 4 | 2019 | 1061 | 0.750 |
Why?
| | Posture | 2 | 2021 | 174 | 0.740 |
Why?
| | Neck | 1 | 2021 | 92 | 0.710 |
Why?
| | Abscess | 1 | 2021 | 73 | 0.710 |
Why?
| | Snoring | 3 | 2015 | 12 | 0.670 |
Why?
| | Cleft Lip | 1 | 2018 | 42 | 0.610 |
Why?
| | Infant | 21 | 2021 | 8997 | 0.600 |
Why?
| | Postoperative Complications | 4 | 2024 | 2497 | 0.590 |
Why?
| | Body Mass Index | 4 | 2021 | 2250 | 0.590 |
Why?
| | Cleft Palate | 1 | 2018 | 63 | 0.590 |
Why?
| | Tongue | 2 | 2015 | 72 | 0.590 |
Why?
| | Airway Obstruction | 2 | 2021 | 157 | 0.580 |
Why?
| | Anesthesia | 3 | 2016 | 130 | 0.580 |
Why?
| | Continuous Positive Airway Pressure | 3 | 2024 | 69 | 0.570 |
Why?
| | Obesity, Morbid | 1 | 2021 | 241 | 0.570 |
Why?
| | Severity of Illness Index | 10 | 2025 | 2768 | 0.570 |
Why?
| | Male | 37 | 2025 | 63248 | 0.530 |
Why?
| | Body Weight | 1 | 2021 | 936 | 0.530 |
Why?
| | Female | 38 | 2025 | 68274 | 0.510 |
Why?
| | Organizational Policy | 1 | 2016 | 76 | 0.500 |
Why?
| | Craniofacial Abnormalities | 1 | 2015 | 62 | 0.470 |
Why?
| | Patient Admission | 1 | 2016 | 185 | 0.460 |
Why?
| | Emergencies | 1 | 2015 | 164 | 0.440 |
Why?
| | Patient Outcome Assessment | 1 | 2015 | 128 | 0.440 |
Why?
| | Oxygen | 4 | 2023 | 913 | 0.440 |
Why?
| | Adolescent | 18 | 2025 | 20241 | 0.420 |
Why?
| | Obesity | 7 | 2023 | 2847 | 0.410 |
Why?
| | Professional Practice | 1 | 2013 | 65 | 0.400 |
Why?
| | Patient Compliance | 1 | 2016 | 563 | 0.390 |
Why?
| | Cross-Sectional Studies | 8 | 2023 | 5036 | 0.380 |
Why?
| | Nasopharynx | 3 | 2022 | 67 | 0.380 |
Why?
| | Cysts | 2 | 2010 | 108 | 0.380 |
Why?
| | Postoperative Hemorrhage | 1 | 2012 | 85 | 0.370 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2010 | 5 | 0.360 |
Why?
| | Dacryocystorhinostomy | 1 | 2010 | 9 | 0.350 |
Why?
| | Prospective Studies | 7 | 2023 | 7070 | 0.350 |
Why?
| | Nasolacrimal Duct | 1 | 2010 | 7 | 0.350 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.340 |
Why?
| | Patient Readmission | 3 | 2024 | 674 | 0.330 |
Why?
| | Practice Guidelines as Topic | 4 | 2019 | 1526 | 0.310 |
Why?
| | Microbiota | 5 | 2023 | 724 | 0.310 |
Why?
| | Overweight | 2 | 2025 | 524 | 0.300 |
Why?
| | Treatment Outcome | 10 | 2024 | 10256 | 0.300 |
Why?
| | Thinness | 2 | 2021 | 89 | 0.300 |
Why?
| | Asthma | 1 | 2021 | 2260 | 0.290 |
Why?
| | Hypoxia | 1 | 2015 | 1071 | 0.290 |
Why?
| | Perioperative Care | 2 | 2021 | 150 | 0.280 |
Why?
| | Tonsillitis | 2 | 2019 | 6 | 0.260 |
Why?
| | Diagnostic Techniques, Otological | 1 | 2006 | 2 | 0.260 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2024 | 52 | 0.260 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 2 | 2010 | 33 | 0.250 |
Why?
| | Infant, Newborn | 8 | 2021 | 5707 | 0.250 |
Why?
| | Patient Selection | 4 | 2024 | 671 | 0.230 |
Why?
| | Shaken Baby Syndrome | 1 | 2004 | 5 | 0.230 |
Why?
| | Esophageal Perforation | 1 | 2004 | 15 | 0.230 |
Why?
| | Head Injuries, Closed | 1 | 2004 | 50 | 0.220 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 153 | 0.220 |
Why?
| | Bronchoscopy | 2 | 2021 | 215 | 0.210 |
Why?
| | Electric Stimulation Therapy | 1 | 2024 | 59 | 0.210 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 93 | 0.210 |
Why?
| | Respiration | 1 | 2024 | 191 | 0.210 |
Why?
| | Olfaction Disorders | 1 | 2023 | 60 | 0.210 |
Why?
| | Turner Syndrome | 1 | 2023 | 51 | 0.210 |
Why?
| | Hypertrophy | 3 | 2015 | 120 | 0.210 |
Why?
| | Disorders of Excessive Somnolence | 1 | 2022 | 26 | 0.200 |
Why?
| | Prader-Willi Syndrome | 1 | 2022 | 27 | 0.200 |
Why?
| | Narcolepsy | 1 | 2022 | 21 | 0.200 |
Why?
| | Preoperative Care | 3 | 2011 | 343 | 0.190 |
Why?
| | Postoperative Period | 2 | 2017 | 320 | 0.190 |
Why?
| | Tracheitis | 1 | 2001 | 3 | 0.190 |
Why?
| | Epiglottitis | 1 | 2001 | 4 | 0.190 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.190 |
Why?
| | Coccidioidomycosis | 1 | 2001 | 7 | 0.190 |
Why?
| | Fluconazole | 1 | 2001 | 18 | 0.190 |
Why?
| | Haemophilus Infections | 1 | 2022 | 40 | 0.190 |
Why?
| | Laryngeal Diseases | 1 | 2001 | 26 | 0.180 |
Why?
| | Fishes | 1 | 2001 | 93 | 0.180 |
Why?
| | Down-Regulation | 2 | 2024 | 639 | 0.180 |
Why?
| | Croup | 1 | 2001 | 27 | 0.180 |
Why?
| | Supine Position | 1 | 2021 | 38 | 0.180 |
Why?
| | Ear, Middle | 4 | 2023 | 93 | 0.180 |
Why?
| | Cytodiagnosis | 1 | 2000 | 32 | 0.180 |
Why?
| | Ciliary Motility Disorders | 1 | 2000 | 23 | 0.170 |
Why?
| | Plasminogen | 1 | 2020 | 31 | 0.170 |
Why?
| | Tertiary Care Centers | 2 | 2023 | 147 | 0.170 |
Why?
| | Drainage | 1 | 2021 | 162 | 0.170 |
Why?
| | Choanal Atresia | 1 | 2000 | 2 | 0.170 |
Why?
| | Foreign Bodies | 1 | 2001 | 102 | 0.170 |
Why?
| | Canada | 2 | 2023 | 355 | 0.170 |
Why?
| | Conscious Sedation | 1 | 2021 | 84 | 0.170 |
Why?
| | Nasal Mucosa | 1 | 2000 | 107 | 0.170 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 25 | 0.160 |
Why?
| | Reproducibility of Results | 4 | 2025 | 3047 | 0.160 |
Why?
| | Pharyngeal Diseases | 1 | 2019 | 14 | 0.160 |
Why?
| | Sleep Wake Disorders | 1 | 2022 | 246 | 0.160 |
Why?
| | Comorbidity | 2 | 2015 | 1542 | 0.160 |
Why?
| | Middle Ear Ventilation | 1 | 2018 | 15 | 0.150 |
Why?
| | Deoxyribonuclease I | 1 | 2018 | 37 | 0.150 |
Why?
| | Tympanic Membrane | 3 | 2006 | 23 | 0.150 |
Why?
| | Symptom Assessment | 1 | 2019 | 127 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2020 | 319 | 0.150 |
Why?
| | Child Abuse | 1 | 2004 | 519 | 0.150 |
Why?
| | Equipment Failure | 1 | 2018 | 112 | 0.150 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2018 | 51 | 0.140 |
Why?
| | Weight Gain | 1 | 2021 | 504 | 0.140 |
Why?
| | Peritonsillar Abscess | 1 | 1997 | 3 | 0.140 |
Why?
| | Tympanic Membrane Perforation | 1 | 1997 | 15 | 0.140 |
Why?
| | Hospitals, Pediatric | 2 | 2023 | 518 | 0.140 |
Why?
| | Pharynx | 2 | 2023 | 56 | 0.140 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 1997 | 85 | 0.140 |
Why?
| | Adult | 9 | 2024 | 35423 | 0.140 |
Why?
| | Case-Control Studies | 3 | 2015 | 3336 | 0.140 |
Why?
| | Surveys and Questionnaires | 6 | 2023 | 5365 | 0.130 |
Why?
| | Biopsy | 1 | 2000 | 1093 | 0.130 |
Why?
| | Streptococcal Infections | 2 | 2005 | 145 | 0.130 |
Why?
| | Regression Analysis | 1 | 2019 | 987 | 0.130 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 778 | 0.130 |
Why?
| | Anti-Bacterial Agents | 3 | 2021 | 1702 | 0.130 |
Why?
| | Stents | 1 | 2000 | 518 | 0.120 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2023 | 521 | 0.120 |
Why?
| | Age Factors | 2 | 2013 | 3137 | 0.120 |
Why?
| | Membrane Proteins | 1 | 2021 | 1102 | 0.120 |
Why?
| | Self Care | 1 | 2017 | 369 | 0.120 |
Why?
| | Anesthetics | 1 | 2014 | 55 | 0.110 |
Why?
| | Quality Improvement | 2 | 2021 | 1103 | 0.110 |
Why?
| | Pedigree | 3 | 2020 | 491 | 0.110 |
Why?
| | Age Distribution | 1 | 2015 | 377 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 2 | 2021 | 2530 | 0.110 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2015 | 146 | 0.110 |
Why?
| | Genetic Variation | 1 | 2018 | 935 | 0.110 |
Why?
| | Turbinates | 1 | 2012 | 16 | 0.100 |
Why?
| | Pharyngitis | 1 | 2012 | 25 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1696 | 0.100 |
Why?
| | Length of Stay | 1 | 2017 | 1128 | 0.100 |
Why?
| | Guideline Adherence | 1 | 2016 | 528 | 0.100 |
Why?
| | Mutation | 2 | 2021 | 3679 | 0.100 |
Why?
| | Premature Birth | 1 | 2015 | 313 | 0.090 |
Why?
| | Orthodontic Appliances | 1 | 2010 | 11 | 0.090 |
Why?
| | United States | 5 | 2023 | 13992 | 0.090 |
Why?
| | Cohort Studies | 1 | 2021 | 5400 | 0.090 |
Why?
| | Health Care Surveys | 1 | 2013 | 560 | 0.090 |
Why?
| | Follow-Up Studies | 4 | 2019 | 4927 | 0.090 |
Why?
| | Nasal Obstruction | 1 | 2010 | 26 | 0.090 |
Why?
| | Young Adult | 2 | 2024 | 12310 | 0.090 |
Why?
| | Oximetry | 1 | 2010 | 86 | 0.090 |
Why?
| | Internet | 1 | 2013 | 616 | 0.080 |
Why?
| | Sensitivity and Specificity | 2 | 2025 | 1842 | 0.070 |
Why?
| | Chinchilla | 2 | 2018 | 37 | 0.070 |
Why?
| | Consensus | 2 | 2021 | 646 | 0.070 |
Why?
| | Respiration, Artificial | 1 | 2010 | 594 | 0.070 |
Why?
| | Chronic Disease | 1 | 2012 | 1717 | 0.060 |
Why?
| | Animals | 7 | 2022 | 34708 | 0.060 |
Why?
| | Postoperative Care | 1 | 2007 | 246 | 0.060 |
Why?
| | Acute Disease | 2 | 2006 | 978 | 0.060 |
Why?
| | Incidence | 1 | 2012 | 2635 | 0.060 |
Why?
| | Amoxicillin | 1 | 2005 | 31 | 0.060 |
Why?
| | Case Management | 1 | 2005 | 64 | 0.060 |
Why?
| | Colorado | 1 | 2015 | 4445 | 0.060 |
Why?
| | Electrosurgery | 1 | 2004 | 43 | 0.060 |
Why?
| | Hypoglossal Nerve | 1 | 2024 | 10 | 0.060 |
Why?
| | Nose Diseases | 1 | 2003 | 12 | 0.060 |
Why?
| | Tertiary Healthcare | 1 | 2023 | 30 | 0.060 |
Why?
| | Palate, Soft | 1 | 2023 | 12 | 0.050 |
Why?
| | Mice | 4 | 2022 | 16583 | 0.050 |
Why?
| | Otitis Media with Effusion | 1 | 2003 | 23 | 0.050 |
Why?
| | Nose | 1 | 2024 | 64 | 0.050 |
Why?
| | Blister | 1 | 2003 | 45 | 0.050 |
Why?
| | Fatal Outcome | 1 | 2004 | 301 | 0.050 |
Why?
| | Single-Blind Method | 2 | 2018 | 273 | 0.050 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2003 | 105 | 0.050 |
Why?
| | Odorants | 1 | 2023 | 147 | 0.050 |
Why?
| | Smell | 1 | 2023 | 132 | 0.050 |
Why?
| | Recurrence | 2 | 2005 | 1013 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2273 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 63 | 0.050 |
Why?
| | Evidence-Based Medicine | 2 | 2019 | 731 | 0.050 |
Why?
| | Injections, Intravenous | 1 | 2001 | 200 | 0.050 |
Why?
| | Biopsy, Needle | 1 | 2001 | 192 | 0.040 |
Why?
| | Laryngoscopy | 1 | 2001 | 100 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 5282 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2000 | 211 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 50 | 0.040 |
Why?
| | Delphi Technique | 1 | 2021 | 220 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 75 | 0.040 |
Why?
| | Finland | 1 | 2019 | 91 | 0.040 |
Why?
| | United Kingdom | 1 | 2000 | 264 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 204 | 0.040 |
Why?
| | Radiography | 1 | 2001 | 864 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2019 | 425 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 185 | 0.040 |
Why?
| | Administration, Topical | 1 | 2018 | 148 | 0.040 |
Why?
| | Risk Factors | 1 | 2012 | 9804 | 0.040 |
Why?
| | ROC Curve | 1 | 2019 | 501 | 0.040 |
Why?
| | Sleep Medicine Specialty | 1 | 2017 | 9 | 0.040 |
Why?
| | Injections, Intralesional | 1 | 1997 | 34 | 0.040 |
Why?
| | Exome | 1 | 2018 | 219 | 0.040 |
Why?
| | Academies and Institutes | 1 | 2017 | 47 | 0.040 |
Why?
| | Electrocoagulation | 1 | 1997 | 37 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2541 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 422 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 674 | 0.030 |
Why?
| | Advisory Committees | 1 | 2017 | 231 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 716 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 875 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2018 | 1306 | 0.030 |
Why?
| | Wound Healing | 1 | 1997 | 310 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1968 | 0.030 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2014 | 181 | 0.030 |
Why?
| | Biomarkers | 1 | 2024 | 3878 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1997 | 1974 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2762 | 0.030 |
Why?
| | Algorithms | 1 | 2000 | 1626 | 0.030 |
Why?
| | Survival Rate | 1 | 1997 | 1886 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2071 | 0.030 |
Why?
| | Inflammation | 1 | 2021 | 2696 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2711 | 0.020 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 189 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2523 | 0.020 |
Why?
| | Orthodontic Appliances, Removable | 1 | 2009 | 1 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 3290 | 0.020 |
Why?
| | Long-Term Care | 1 | 2009 | 88 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 1997 | 3999 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 4867 | 0.020 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2005 | 71 | 0.010 |
Why?
| | Texas | 1 | 2005 | 227 | 0.010 |
Why?
| | Patient Education as Topic | 1 | 2009 | 735 | 0.010 |
Why?
| | Earache | 1 | 2003 | 4 | 0.010 |
Why?
| | Analgesics | 1 | 2005 | 165 | 0.010 |
Why?
| | Streptococcus pneumoniae | 1 | 2005 | 157 | 0.010 |
Why?
| | Personal Satisfaction | 1 | 2005 | 198 | 0.010 |
Why?
| | Pain, Postoperative | 1 | 2004 | 227 | 0.010 |
Why?
| | Fever | 1 | 2003 | 301 | 0.010 |
Why?
| | Recovery of Function | 1 | 2004 | 642 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 31024 | 0.010 |
Why?
| | Safety | 1 | 1997 | 330 | 0.010 |
Why?
| | Hospitalization | 1 | 1997 | 2080 | 0.000 |
Why?
|
|
Friedman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|